Phase XIII, group 1 - 01.07.2017 - 30.06.2020

Ca.-No 176

Dynamic changes in the chromatin-bound p53 interactome in normal and cancer cells

Israeli Partner: M. Oren, Weizmann Institute
German Partner: J. Krijgsveld, DKFZ

Publications

Ca.-No 177

lnvestigation of the permissiveness to chromothripsis in the context of the lineage, the differentiation status and the mitotic state of cells with compromised p53 or ATM function

Israeli Partner: Y. Bugamin, Hebrew University
German Partner: P. Lichter, A. Ernst, DKFZ

Publications

Ca.-No 178

Reciprocal tumor -blood vessels communication impacting on cancer progression and metastasis.

Israeli Partner: E. Keshet, Hebrew University
German Partner: A. Fischer, DKFZ

Ca.-No 179

Cancerous impact of chronic stress-hematopoiesis

Israeli Partner: R. Gazit, Ben-Gurion University
German Partner: M. Milsom, DKFZ

Ca.-No 180

Deciphering the ‘histone code’ and tumor suppressor functions of the ATRX chromatin network

Israeli Partner: E. Meshorer, Hebrew University
German Partner: K. Rippe, DKFZ

Ca.-No 181

The role of neutrophils and myeloid-derived suppressor cells (MDSC) in metastatic cancer lesions and their effect on existing immunotherapies

Israeli Partner: Z. Fridlender, Hadassah Medical Center
German Partner: V. Umansky, DKFZ

Publications

Formular

Formulardaten werden geladen ...